Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels

A quantitative description of membrane current and its application to conduction and excitation in nerve

Hodgkin, A. L., & Huxley, A. F. (1952) · The Journal of Physiology · doi:10.1113/jphysiol.1952.sp004764 · Cited by 23,191

An SCN9A channelopathy causes congenital inability to experience pain

Cox, J. J., Reimann, F. M., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,605

The crystal structure of a voltage-gated sodium channel

Payandeh, J., Scheuer, T., Zheng, N., & Catterall, W. A. (2011) · Nature · doi:10.1038/nature10238 · Cited by 1,453

Molecular Determinants of State-Dependent Block of Na + Channels by Local Anesthetics

Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1994) · Science · doi:10.1126/science.8085162 · Cited by 839

Voltage‐gated sodium channels at 60: structure, function and pathophysiology

Catterall, W. A. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224204 · Cited by 728

Voltage-gated ion channels and gating modifier toxins

Catterall, W. A., Cestèle, S., Yarov-Yarovoy, V. M., Yu, F. H., Konoki, K., & Scheuer, T. (2006) · Toxicon · doi:10.1016/j.toxicon.2006.09.022 · Cited by 649

Ion Channel Voltage Sensors: Structure, Function, and Pathophysiology

Catterall, W. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.021 · Cited by 570

Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.

Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9270 · Cited by 500

Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders

Mantegazza, M., Curia, G., Biagini, G., Ragsdale, D. S., & Avoli, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70059-4 · Cited by 462

Molecular Determinants of High Affinity Binding of α-Scorpion Toxin and Sea Anemone Toxin in the S3-S4 Extracellular Loop in Domain IV of the Na+ Channel α Subunit

Rogers, J. C., Qu, Y., Tanada, T. N., Scheuer, T., & Catterall, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15950 · Cited by 411

New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation

Taleb, A., Zhou, Y., Meng, L., Zhu, M.-Y., Zhang, Q., Naveed, M., Li, L., Wang, P., Zhou, Q., Meng, F. J., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105636 · Cited by 27

Control of Neurotransmission by NaV1.7 in Human, Guinea Pig, and Mouse Airway Parasympathetic Nerves

Kočmálová, M., Kollárik, M., Canning, B. J., Ru, F., Herbstsomer, R. A., Meeker, S., Fonquerna, S., Aparici, M., Miralpeix, M., Chi, X. X., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.238469 · Cited by 27

Computer-aided Discovery of a New Nav1.7 Inhibitor for Treatment of Pain and Itch

Chandra, S., Wang, Z., Tao, X., Ouyang, C., Luo, X., Ji, R., & Bortsov, A. V. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003427 · Cited by 26

Activation of peripheral KCNQ channels relieves gout pain

Zheng, Y., Xu, H., Zhan, L., Zhou, X., Chen, X., & Gao, Z. (2015) · Pain · doi:10.1097/j.pain.0000000000000122 · Cited by 26

Recent advances in the pharmacology of voltage-gated ion channels

Mateos, D. L., Harris, B. J., Hernández-González, A., Yarov-Yarovoy, V. M., & Wulff, H. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100090 · Cited by 30

Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays

Kraus, R. L., Zhao, F., Pall, P. S., Zhou, D., Vardigan, J. D., Danziger, A., Li, Y., Daley, C., Ballard, J. E., Clements, M. K., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1050 · Cited by 25

Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening

Rogers, M., Zidar, N., Kikelj, D., & Kirby, R. W. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.704 · Cited by 25

Inhibition of Na V 1.7: the possibility of ideal analgesics

Kitano, Y., & Shinozuka, T. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00081d · Cited by 24

Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy

Masala, N., Pofahl, M., Haubrich, A. N., Islam, K. U. S., Nikbakht, N., Pasdarnavab, M., Bohmbach, K., Araki, K., Kamali, F., Henneberger, C., et al. (2022) · Brain · doi:10.1093/brain/awac455 · Cited by 25

N-Aryl-2,6-dimethylbenzamides, a New Generation of Tocainide Analogues as Blockers of Skeletal Muscle Voltage-Gated Sodium Channels

Muraglia, M., Bellis, M. D., Catalano, A. A., Carocci, A., Franchini, C., Carrieri, A., Fortugno, C., Bertucci, C., Desaphy, J., Luca, A. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401864b · Cited by 24

The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement

La, D. S., Peterson, E. A., Bode, C., Boezio, A. A., Bregman, H. S., Chu‐Moyer, M. Y., Coats, J. R., DiMauro, E. F., Dineen, T. A., Du, B., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.070 · Cited by 23

Enhancing inactivation rather than reducing activation of Nav1.7 channels by a clinically effective analgesic CNV1014802

Zheng, Y., Wang, W.-F., Li, Y.-F., Yu, Y. Q., & Gao, Z. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.151 · Cited by 23

Human neuronal signaling and communication assays to assess functional neurotoxicity

Loser, D., Schaefer, J., Danker, T., Möller, C., Brüll, M., Suciu, I., Ückert, A., Klima, S., Leist, M., & Kraushaar, U. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02956-3 · Cited by 24

Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome

Jiang, Y., Castro, J., Blomster, L. V., Agwa, A. J., Maddern, J., Schober, G., Herzig, V., Chow, C. Y., Cardoso, F. C., França, P. D. D. S., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00072 · Cited by 23

Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation

Wu, Y., Guernon, J. M., McClure, A. C., Luo, G., Rajamani, R., Ng, A., Easton, A. E., Newton, A. E., Bourin, C., Parker, D. D., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.012 · Cited by 22

Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats

Li, J., Stratton, H. J., Lorca, S. A., Grace, P. M., & Khanna, R. (2022) · Channels · doi:10.1080/19336950.2021.2023383 · Cited by 22

Sodium Channel Nav1.3 Is Expressed by Polymorphonuclear Neutrophils during Mouse Heart and Kidney Ischemia In Vivo and Regulates Adhesion, Transmigration, and Chemotaxis of Human and Mouse Neutrophils In Vitro

Poffers, M., Bühne, N., Herzog, C., Thorenz, A., Chen, R., Güler, F., Hage, A., Leffler, A., & Echtermeyer, F. G. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002135 · Cited by 22

Similar excitability through different sodium channels and implications for the analgesic efficacy of selective drugs

Xie, Y.-F., Yang, J., Ratté, S., & Prescott, S. A. (2024) · eLife · doi:10.7554/elife.90960.3 · Cited by 33

The tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity

Wingerd, J. S., Mozar, C. A., Ussing, C. A., Murali, S. S., Chin, Y. K. ‐., Cristofori‐Armstrong, B., Durek, T., Gilchrist, J. M., Vaughan, C. W., Bosmans, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01129-0 · Cited by 21

Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1

Touška, F., Sattler, S., Malsch, P., Lewis, R. J., Reeh, P. W., & Zimmermann, K. (2017) · Marine Drugs · doi:10.3390/md15090269 · Cited by 21

The AMPK Activator A769662 Blocks Voltage-Gated Sodium Channels: Discovery of a Novel Pharmacophore with Potential Utility for Analgesic Development

Asiedu, M. N., Han, C., Dib‐Hajj, S. D., Waxman, S. G., Price, T. J., & Dussor, G. O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169882 · Cited by 21

Bibliometric analysis of recent sodium channel research

Zhao, D., Li, J., Seehus, C. R., Huang, X., Zhao, M., Zhang, S., Wang, W., Ji, H., & Guo, F. (2018) · Channels · doi:10.1080/19336950.2018.1511513 · Cited by 21

Combination Formulation of Tetrodotoxin and Lidocaine as a Potential Therapy for Severe Arrhythmias

Hong, B., He, J., Le, Q., Bai, K., Chen, Y., & Huang, W. (2019) · Marine Drugs · doi:10.3390/md17120685 · Cited by 20

ST‐2560, a selective inhibitor of the NaV1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates

Mulcahy, J. V., Beckley, J. T., Klas, S., Odink, D. A., Delwig, A., Pajouhesh, H., Monteleone, D., Zhou, X., Bois, J. D., Yeomans, D. C., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16398 · Cited by 20

Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels

Miceli, F., Soldovieri, M. V., Ambrosino, P., Maria, M. D., Manocchio, L., Medoro, A., & Taglialatela, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00259 · Cited by 20

Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?

Li, Z., Chen, L.-X., & Li, H. (2019) · Current Medical Science · doi:10.1007/s11596-019-2117-0 · Cited by 19

Inhibition of Sodium Ion Channel Function with Truncated Forms of Batrachotoxin

Toma, T., Logan, M. M., Ménard, F., Devlin, A. S., & Bois, J. D. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00212 · Cited by 18

A compendium of validated pain genes

Wistrom, E., Chase, R., Smith, P. R., & Campbell, Z. T. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1570 · Cited by 17

A Buthus martensii Karsch scorpion sting targets Nav1.7 in mice and mimics a phenotype of human chronic pain

Lu, W., Cheng, X., Chen, J., Wang, M., Chen, Y., Liu, J., Sang, M., Zhao, N., Yan, H., Cheng, X., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002397 · Cited by 16

Targeted blockade of aberrant sodium current in a stem cell-derived neuron model of SCN3A encephalopathy

Qu, G., Merchant, J. P., Clatot, J., DeFlitch, L., Frederick, D. J., Tang, S., Salvatore, M., Zhang, X., Li, J., Anderson, S. A., et al. (2023) · Brain · doi:10.1093/brain/awad376 · Cited by 15

Theoretical and simulation studies on voltage-gated sodium channels

Li, Y., & Gong, H. (2015) · Protein & Cell · doi:10.1007/s13238-015-0152-6 · Cited by 15

EVAP: A two-photon imaging tool to study conformational changes in endogenous Kv2 channels in live tissues

Thapa, P., Stewart, R. G., Sepela, R. J., Vivas, O., Parajuli, L. K., Lillya, M. W., Fletcher-Taylor, S., Cohen, B. E., Zito, K., & Sack, J. T. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202012858 · Cited by 16

Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Stoilova‐McPhie, S., Ali, S. R., & Laezza, F. (2013) · PubMed · Cited by 15

Reporting Sodium Channel Activity Using Calcium Flux: Pharmacological Promiscuity of Cardiac Nav1.5

Zhang, H., Zou, B., Du, F., Xu, K., & Li, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094789 · Cited by 15

Role of voltage-gated sodium channels in axonal signal propagation of trigeminal ganglion neurons after infraorbital nerve entrapment

Mulpuri, Y., Yamamoto, T., Nishimura, I., & Spigelman, I. (2022) · Neurobiology of Pain · doi:10.1016/j.ynpai.2022.100084 · Cited by 14

Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors

Wu, Y., Guernon, J. M., McClure, A. C., Venables, B. L., Rajamani, R., Robbins, K. J., Knox, R. J., Matchett, M., Pieschl, R. L., Herrington, J. B., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.035 · Cited by 14

Voltage-gated sodium channels in cancer and their specific inhibitors

Bian, Y., Tuo, J., He, L., Li, W., Li, S., Chu, H., & Zhao, Y. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154909 · Cited by 13

Role of NaV1.7 in postganglionic sympathetic nerve function in human and guinea‐pig arteries

Kim, J. S., Meeker, S., Ru, F., Tran, M., Zabka, T. S., Hackos, D. H., & Undem, B. J. (2024) · The Journal of Physiology · doi:10.1113/jp286538 · Cited by 13

Molecular game theory for a toxin-dominant food chain model

Li, B., Silva, J. R., Lu, X., Luo, L., Wang, Y., Xu, L., Aierken, A., Shynykul, Z., Kamau, P. M., Luo, A., et al. (2019) · National Science Review · doi:10.1093/nsr/nwz097 · Cited by 13

General mechanism of spider toxin family I acting on sodium channel Nav1.7

Yuan, F., 湖南师范大学生命科学学院动物多肽药物创制国家地方联合工程实验室, 湖. 长., Sun, F., Zhang, L., Huang, B., An, H.-L., Rong, M., Du, C., 河北工业大学健康科学与生物医学工程学院生物物理研究所河北省分子生物物理重点实验室, 天. 3., & 成都佩德生物医药有限公司, 四. 成. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.185 · Cited by 13

Selective targeting of voltage-gated sodium channels to achieve analgesia: current status and future directions

Gordon, E. A., Tyagi, S., Dib‐Hajj, S. D., & Bennett, D. (2025) · Pain · doi:10.1097/j.pain.0000000000003639 · Cited by 13

Suzetrigine, a NaV1.8 Inhibitor as a Novel Approach for Pain Therapy—A Medicinal and Chemical Drug Profile

Medhat, R. M., Kotb, O., & Baecker, D. (2026) · Molecules · doi:10.3390/molecules31020358 · Cited by 12

Similar excitability through different sodium channels and implications for the analgesic efficacy of selective drugs

Xie, Y., Yang, J., Ratté, S., & Prescott, S. A. (2023) · eLife · doi:10.7554/elife.90960 · Cited by 35

Unusual Voltage-Gated Sodium Currents as Targets for Pain

Barbosa, C., & Cummins, T. (2016) · Current topics in membranes · doi:10.1016/bs.ctm.2015.12.005 · Cited by 12

Lacosamide Inhibition of NaV1.7 Channels Depends on its Interaction With the Voltage Sensor Domain and the Channel Pore

Labau, J. I. R., Alsaloum, M., Estación, M., Tanaka, B. S., Dib-Hajj, F. B., Lauria, G., Smeets, H. J. M., Faber, C. G., Dib‐Hajj, S. D., & Waxman, S. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.791740 · Cited by 12

Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771

Jo, S., & Bean, B. P. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.118380 · Cited by 12

A Solid Supported Membrane-Based Technology for Electrophysical Screening of B0AT1-Modulating Compounds

Gerbeth-Kreul, C., Pommereau, A., Ruf, S. G., Kane, J. L. J., Kuntzweiler, T. A., Heßler, G., Engel, C. K., Shum, P. W., Wei, L., Czech, J., et al. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211011180 · Cited by 12

Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis

Pukkanasut, P., Jaskula‐Sztul, R., Gómora, J. C., & Velu, S. E. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1416705 · Cited by 11

The discovery of a potent Na v 1.3 inhibitor with good oral pharmacokinetics

Pryde, D. C., Swain, N. A., Stupple, P. A., West, C. W., Marron, B. E., Markworth, C. J., Printzenhoff, D., Lin, Z., Cox, P. J., Suzuki, R., et al. (2017) · MedChemComm · doi:10.1039/c7md00131b · Cited by 11

N-Aryl azacycles as novel sodium channel blockers

Lynch, S. M., Tafesse, L., Carlin, K. P., Ghatak, P., Shao, B., Abdelhamid, H., & Kyle, D. J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.023 · Cited by 11

Action of Clathrodin and Analogues on Voltage-Gated Sodium Channels

Peigneur, S., Žula, A., Zidar, N., Chan-Porter, F., Kirby, R. W., Madge, D. J., Ilaš, J., Kikelj, D., & Tytgat, J. (2014) · Marine Drugs · doi:10.3390/md12042132 · Cited by 11

A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site

Rajamani, R., Wu, S., Rodrigo, I., Gao, M., Low, S., Megson, L., Wensel, D. L., Pieschl, R. L., Post-Munson, D. J., Watson, J., et al. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108712 · Cited by 11

Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia

Teng, M., Wu, W., Li, Z., Yang, G., Qin, J., Wang, Y., Hu, Z., Dong, H., Hou, L., Hu, G., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.010 · Cited by 11

Chemical and Biological Tools for the Study of Voltage‐Gated Sodium Channels in Electrogenesis and Nociception

Elleman, A. V., & Bois, J. D. (2022) · ChemBioChem · doi:10.1002/cbic.202100625 · Cited by 10

Physical basis of specificity and delayed binding of a subtype selective sodium channel inhibitor

Corry, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-19850-9 · Cited by 10

Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5

Finley, M., Cassaday, J., Kreamer, T., Li, X.-N., Solly, K. J., O'Donnell, G., Clements, M. K., Converso, A., Cook, S. P., Daley, C., et al. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116629669 · Cited by 10

Characterization of Synthetic Tf2 as a NaV1.3 Selective Pharmacological Probe

Israel, M. R., Dash, T. S., Bothe, S., Robinson, S. D., Deuis, J. R., Craik, D. J., Lampert, A., Vetter, I., & Durek, T. (2020) · Biomedicines · doi:10.3390/biomedicines8060155 · Cited by 10

Current Nonopioid Small Molecule Approaches Toward the Treatment of Neuropathic Pain

Cioffi, C. L., Lotsaris, I., Chater, R. C., Pati, T. K., Suleria, K., Mahesh, G., Singh, S., Peiser-Oliver, J., Mohammadi, S. A., & Vandenberg, R. J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01126 · Cited by 9

Functional confirmation that the R1488* variant in SCN9A results in complete loss-of-function of Nav1.7

He, W., Young, G. T., Zhang, B., Cox, P. J., Cho, L. T. Y., John, S., Paciga, S. A., Wood, L. S., Danziger, N., Scollen, S., et al. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0643-4 · Cited by 9

Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core

Wang, J., Zheng, Y., Chen, Y., Gu, M., Gao, Z., & Nan, F. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0267-z · Cited by 9

An unbiased and efficient assessment of excitability of sensory neurons for analgesic drug discovery

Mohammed, Z. A., Kaloyanova, K., & Nassar, M. A. (2020) · Pain · doi:10.1097/j.pain.0000000000001802 · Cited by 9

Role of NaV1.7 in action potential conduction along human bronchial vagal afferent C‐fibres

Kollárik, M., Ru, F., Pavelková, N., Mulcahy, J. V., Hunter, J. C., & Undem, B. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15686 · Cited by 9

Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors

Schenkel, L. B., DiMauro, E. F., Nguyen, H. N., Chakka, N., Du, B., Foti, R., Guzmán-Pérez, A., Jarosh, M., La, D. S., Ligutti, J., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.054 · Cited by 9

The contribution of NaV1.6 to the efficacy of voltage‐gated sodium channel inhibitors in wild type and NaV1.6 gain‐of‐function (GOF) mouse seizure control

Johnson, J. P., Focken, T., Tari, P. K., Dubé, C. M., Goodchild, S. J., Andrez, J., Bankar, G. R., Burford, K., Chang, E., Chowdhury, S., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16481 · Cited by 9

Toward high-resolution modeling of small molecule–ion channel interactions

Harris, B. J., Nguyen, P. T., Zhou, G., Wulff, H., DiMaio, F., & Yarov-Yarovoy, V. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1411428 · Cited by 8

Discovery and optimisation of potent and highly subtype selective Na v 1.8 inhibitors with reduced cardiovascular liabilities

Bagal, S. K., Kemp, M. I., Bungay, P. J., Hay, T. L., Murata, Y., Payne, C. E., Stevens, E. B., Brown, A. D., Blakemore, D. C., Corbett, M. S., et al. (2016) · MedChemComm · doi:10.1039/c6md00281a · Cited by 8

Conformational Mechanisms of Signaling Bias of Ion Channels

Herrington, J. B., & Arey, B. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411460-9.00006-9 · Cited by 10

Functional Studies of Sodium Channels: From Target to Compound Identification

Bertrand, D., Biton, B., Licher, T., Chambard, J., Lanneau, C., Partiseti, M., & Lefevre, I. A. (2016) · Current Protocols in Pharmacology · doi:10.1002/cpph.14 · Cited by 8

Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors

Wu, Y., Venables, B. L., Guernon, J. M., Chen, J., Sit, S., Rajamani, R., Knox, R. J., Matchett, M., Pieschl, R. L., Herrington, J. B., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.013 · Cited by 8

Discovery of Novel Na v 1.7-Selective Inhibitors with the 1 H -Indole-3-Propionamide Scaffold for Effective Pain Relief

Wang, G., Wu, H., Wang, Y., Liu, X., Peng, S., Wang, W., Wu, M., Liu, Y., Wang, E., Wang, Z., et al. (2025) · Research · doi:10.34133/research.0599 · Cited by 9

New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3 voltage-gated sodium channel

Zidar, N., Tomašič, T., Kikelj, D., Durcik, M., Tytgat, J., Peigneur, S., Rogers, M., Haworth, A. S., & Kirby, R. W. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115530 · Cited by 7

Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting NaV1.7 for pain alleviation

Zhang, Y., Ding, Y., Zeng, Z., Zhu, R., Zheng, P., Fan, S., Cao, Q., Chen, H., Ren, W., Wu, M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101800 · Cited by 7

IonWorks Barracuda Assay for Assessment of State-Dependent Sodium Channel Modulators

Cerne, R., Wakulchik, M., Krambis, M. J., Burris, K. D., & Priest, B. T. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.677 · Cited by 7

PF‐06526290 can both enhance and inhibit conduction through voltage‐gated sodium channels

Wang, L., Zellmer, S. G., Printzenhoff, D., & Castle, N. A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14338 · Cited by 7

Biaryl sulfonamide motifs up- or down-regulate ion channel activity by activating voltage sensors

Liin, S. I., Lund, P.-E., Larsson, J. E., Brask, J., Wallner, B., & Elinder, F. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201711942 · Cited by 7

Recent advances in computational studies on voltage‐gated sodium channels: Drug design and mechanism studies

Wang, G., Xu, L., Chen, H., Liu, Y., Pan, P., & Hou, T. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1641 · Cited by 7

Permethrin induces epileptic susceptibility via activation of Na+ channels and rise in glutamate

Su, M., Zhang, Y., Feng, Z. G., Li, W., Liu, Y., Xu, C., Zhao, C., Kwan, P., Tian, X., & Li, L. (2025) · Communications Biology · doi:10.1038/s42003-025-09037-0 · Cited by 6

Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives

Paruch, K., Kaproń, B., Łuszczki, J. J., Paneth, A., & Plech, T. (2023) · Molecules · doi:10.3390/molecules28135287 · Cited by 6

Eugenol and lidocaine inhibit voltage-gated Na+ channels from dorsal root ganglion neurons with different mechanisms

Moreira‐Júnior, L., Leal‐Cardoso, J. H., Cassola, A. C., & Carvalho-de-Souza, J. L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1354737 · Cited by 6

Fast voltage‐dependent sodium (Na V ) currents are functionally expressed in mouse corpus cavernosum smooth muscle cells

Lim, X. R., Bradley, E., Griffin, C. S., Hollywood, M. A., Sergeant, G. P., & Thornbury, K. D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15728 · Cited by 6

VGSC-DB: an online database of voltage-gated sodium channels

Wang, G., Yu, J., Du, H., Shen, C., Zhang, X., Liu, Y., Zhang, Y., Cao, D., Pan, P., & Hou, T. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00655-y · Cited by 6

A versatile residue numbering scheme for Nav and Cav channels

Jin, X., Huang, J., Wang, H., Wang, K., & Yan, N. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.07.008 · Cited by 5

Voltage-Gated Sodium Channel Pharmacology

Chen, R., Buyan, A., & Corry, B. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.02.002 · Cited by 6

Pharmacological Dissection of the Crosstalk between NaV and CaV Channels in GH3b6 Cells

Réthoré, L., Park, J., Montnach, J., Nicolas, S., Khoury, J., Seac’h, E. L., Mabrouk, K., de Pomyers, H., Tricoire-Leignel, H., Mattei, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020827 · Cited by 6

The small molecule compound C65780 alleviates pain by stabilizing voltage-gated sodium channels in the inactivated and slowly-recovering state

Kong, X., Li, Y., Perez‐Miller, S., Luo, G., Liao, Q., Wu, X., Liang, S., Tang, C. W., Khanna, R., & Liu, Z. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109057 · Cited by 5

Action potential conduction in the mouse and rat vagus nerve is dependent on multiple voltage-gated sodium channels (NaV1s)

Nair, S. S., Pavelková, N., Murphy, C. M., Kollárik, M., & Taylor‐Clark, T. E. (2023) · Journal of Neurophysiology · doi:10.1152/jn.00041.2023 · Cited by 5

Activation of reverse Na+-Ca2+ exchanger by skeletal Na+ channel isoform increases excitation-contraction coupling efficiency in rabbit cardiomyocytes

Torres, N. S. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00545.2020 · Cited by 5

Fluorescent toxins as ion channel activity sensors

Stewart, R. G., Cohen, B. E., & Sack, J. T. (2021) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2021.02.014 · Cited by 5

Neuropathische Schmerzen durch Nav1.7-Mutationen

Doppler, K., & Sommer, C. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3621-7 · Cited by 5

Stimulus intensity-dependent recruitment of NaV1 subunits in action potential initiation in nerve terminals of vagal C-fibers innervating the esophagus

Ru, F., Pavelková, N., Krajewski, J. L., McDermott, J. S., Undem, B. J., & Kollárik, M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00122.2019 · Cited by 5

Sarcandra glabra (Thunb.) Nakai relieves pain behavior by inhibiting NaV1.7 channels

Yang, X., He, Y., Li, Z., Zhou, X., Mu, L., Wu, J., & Yang, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120002 · Cited by 4

Pathophysiological roles and therapeutic potential of voltage-gated ion channels (VGICs) in pain associated with herpesvirus infection

Zhang, Q., Martin‐Caraballo, M., & Hsia, S. V. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00430-2 · Cited by 4

Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5

Sun, S., Jia, Q., Zenova, A., Lin, S., Hussainkhel, A., Mezeyova, J., Chang, E., Goodchild, S. J., Xie, Z., Lindgren, A., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128133 · Cited by 4

Voltage-Gated Sodium Channels as Drug Targets in Epilepsy-Related Sodium Channelopathies

Wengert, E. R., Miralles, R. M., & Patel, M. K. (2024) · Springer eBooks · doi:10.1007/978-3-031-52197-3_4 · Cited by 4

Effects of NaV1.5 and Rac1 on the Epithelial-Mesenchymal Transition in Breast Cancer

Zha, Z., Ge, F., Li, N., Zhang, S., Wang, C., Gong, F., Miao, J., & Chen, W. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01625-x · Cited by 4

Investigation of the selectivity of one type of small-molecule inhibitor for three Nav channel isoforms based on the method of computer simulation

Zhao, F., Jin, W., Ma, L., Zhang, J., Wang, J., Zhang, J., & Song, Y. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1438921 · Cited by 4

Multitargeting in cardioprotection: An example of biaromatic compounds

Мокров, Г. В. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202300196 · Cited by 4

Sodium Channel Blockers for the Treatment of Pain

Witty, D. R., MacPherson, D. T., & Giblin, G. M. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12439-4 · Cited by 4

Voltage sensor interaction site for a selective small molecule Nav1.1 sodium channel potentiator that enhances firing of fast-spiking interneurons

Gallucci, A., Potet, F., Santos, S., Lin, Z., Theile, J. W., Yoger, K., Ren, W., Wang, L., Lebreton, S., Attinost, I., et al. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100072 · Cited by 3

Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist

Ahuja, S., Mukund, S., Deng, L., Khakh, K., Chang, E., Ho, H., Shriver, S., Young, C., Lin, S., Johnson, J. P., et al. (2015) · Science · doi:10.1126/science.aac5464 · Cited by 319

Identification and characterization of selective inhibitors of Nav1.9 voltage dependent sodium channels

Potet, F., Santos, S., Gallucci, A., Theile, J. W., Yoger, K., Lin, Z., Lebreton, S., Volkmann, R., Dow, R., Elban, M. A., et al. (2026) · Molecular Pharmacology · doi:10.1016/j.molpha.2026.100125

The tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity

Wingerd, J. S., Mozar, C. A., Ussing, C. A., Murali, S. S., Chin, Y. K. ‐., Cristofori‐Armstrong, B., Durek, T., Gilchrist, J. M., Vaughan, C. W., Bosmans, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01129-0 · Cited by 21

Deconstructing voltage sensor function and pharmacology in sodium channels

Bosmans, F., Martin‐Eauclaire, M., & Swartz, K. J. (2008) · Nature · doi:10.1038/nature07473 · Cited by 262

Using Potassium Channels As Reporters To Deconstruct The Function And Pharmacology Of Sodium Channel Voltage Sensors

Bosmans, F., Martin‐Eauclaire, M., & Swartz, K. J. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.12.961